Cart
sales@molnova.com
Eribaxaban
CAS No. 536748-46-6
Eribaxaban( PD-0348292 | PD0348292 | PD 0348292 )
Catalog No. M14904 CAS No. 536748-46-6
A potent, selective and orally efficacious factor Xa (FXa) inhibitor with IC50 of 0.32 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
| 5MG | 85 | In Stock |
|
| 10MG | 136 | In Stock |
|
| 25MG | 226 | In Stock |
|
| 50MG | 332 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEribaxaban
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective and orally efficacious factor Xa (FXa) inhibitor with IC50 of 0.32 nM.
-
DescriptionA potent, selective and orally efficacious factor Xa (FXa) inhibitor with IC50 of 0.32 nM; displays >1,000-fold selectivity over a series of related serine proteases (thrombin, activated protein C, plasmin, tissue plasminogen activator and trypsin); potently inhibits thrombosis and shows potential for s for the treatment and prevention of thrombotic disorders.Thrombosis Phase 2 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsPD-0348292 | PD0348292 | PD 0348292
-
PathwayMetabolic Enzyme/Protease
-
TargetFactor Xa
-
RecptorFactor Xa
-
Research AreaCardiovascular Disease
-
IndicationThrombosis
Chemical Information
-
CAS Number536748-46-6
-
Formula Weight484.912
-
Molecular FormulaC24H22ClFN4O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=CC=C(Cl)C=C1)N2C[C@@H](C[C@H]2C(NC3=CC=C(N4C=CC=CC4=O)C=C3F)=O)OC
-
Chemical Name(2R,4R)-1-N-(4-chlorophenyl)-2-N-[2-fluoro-4-(2-oxopyridin-1-yl)phenyl]-4-methoxypyrrolidine-1,2-dicarboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kohrt JT, et al. Chem Biol Drug Des. 2007 Aug;70(2):100-12.
2. McBane RD 2nd, et al. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):413-8.
3. Karnicki K, et al. Thromb Haemost. 2008 Apr;99(4):759-66.
4. Cohen AT, et al. J Thromb Haemost. 2013 Aug;11(8):1503-10.
molnova catalog
related products
-
MLN0905
MLN0905 is an effective PLK1 inhibitor(IC50=2 nM).
-
Rivaroxaban
A highly potent and selective, direct FXa inhibitor with IC50 of 0.7 nM.
-
Darexaban
A potent, selective and orally available factor Xa (FXa) inhibitor with IC50 of 54.6 nM.
